Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants accelerated approval to Zepzelca for metastatic SCLC

June 16, 2020

Favorable safety, pharmacodynamic activity seen with FT-4202 in phase I study

June 16, 2020

The Treg-selective long-acting IL-2 variant CUG-252 reduces inflammation in vitro and in vivo

June 16, 2020

Janssen discovers compounds active against respiratory syncytial virus

June 16, 2020

New dual CDK-HDAC inhibitors synthesized at Hangzhou Innogate Pharma

June 16, 2020

New Mnk1 and Mnk2 inhibitors discovered at Shanghai De Novo Pharmatech

June 16, 2020

Shanghai Pharmaceuticals Holding patents MAPK11 and 14 inhibitors

June 16, 2020

New SHP-2 inhibitors identified at Tuojie Biotech

June 16, 2020

Phase II data presented from ORIENT-2 study of sintilimab advanced refractory ESCC

June 16, 2020

RICTOR as a new therapeutic target for lung cancer brain metastases

June 16, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...